Evoke Pharma Inc (EVOK) — Working Capital to Net Assets Ratio
Evoke Pharma Inc (EVOK) has a Working Capital to Net Assets ratio of 98.0% as of September 2025. Working capital of $3.30 Million (current assets of $15.54 Million minus current liabilities of $12.24 Million) is measured against net assets of $3.36 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Evoke Pharma Inc (EVOK) liquidity interval to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Evoke Pharma Inc Working Capital to Net Assets (2011–2024)
This chart shows how Evoke Pharma Inc's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2011 to 2024. As of September 2025, the ratio stands at 98.0%, reflecting working capital of $3.30 Million against net assets of $3.36 Million USD. For the complete balance sheet picture, see Evoke Pharma Inc (EVOK) total assets.
Annual Working Capital to Net Assets for Evoke Pharma Inc (2011–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Evoke Pharma Inc from 2011 to 2024, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check EVOK asset resilience ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 97.4% | $6.86 Million | $7.04 Million | $17.24 Million | $10.38 Million | ▼ -11.9 pp |
| 2023 | 109.4% | $-2.82 Million | $-2.58 Million | $6.83 Million | $9.65 Million | ▼ -137.1 pp |
| 2022 | 246.5% | $10.07 Million | $4.08 Million | $11.72 Million | $1.65 Million | ▼ -11.0 pp |
| 2021 | 257.5% | $9.15 Million | $3.56 Million | $10.56 Million | $1.41 Million | ▲ +311.8 pp |
| 2020 | -54.3% | $1.75 Million | $-3.21 Million | $9.28 Million | $7.54 Million | ▼ -150.9 pp |
| 2019 | 96.6% | $4.23 Million | $4.38 Million | $6.25 Million | $2.02 Million | ▼ -3.1 pp |
| 2018 | 99.7% | $4.01 Million | $4.03 Million | $5.65 Million | $1.63 Million | ▼ -170.7 pp |
| 2017 | 270.4% | $5.86 Million | $2.17 Million | $7.93 Million | $2.07 Million | ▲ +62.6 pp |
| 2016 | 207.8% | $7.87 Million | $3.79 Million | $9.28 Million | $1.41 Million | ▼ -14.1 pp |
| 2015 | 221.9% | $7.69 Million | $3.46 Million | $9.52 Million | $1.83 Million | ▲ +76.4 pp |
| 2014 | 145.6% | $13.38 Million | $9.19 Million | $15.25 Million | $1.87 Million | ▲ +41.0 pp |
| 2013 | 104.5% | $22.15 Million | $21.18 Million | $24.43 Million | $2.28 Million | ▲ +102.2 pp |
| 2012 | 2.3% | $-454.40K | $-19.66 Million | $116.01K | $570.41K | ▲ +5.5 pp |
| 2011 | -3.2% | $570.84K | $-17.65 Million | $905.34K | $334.50K | — |